HK Brar, J Jose, Z Wu, M Sharma - Pharmaceutics, 2022 - mdpi.com
Glioblastoma multiforme (GBM) is an aggressive brain tumor with high mortality rates. Due to its invasiveness, heterogeneity, and incomplete resection, the treatment is very challenging …
Despite significant improvements in pediatric brain tumor therapy and outcome, too many children still die of disease, and too many survivors experience significant sequelae as a …
The global impact of somatic structural variants (SSVs) on gene expression in pediatric brain tumors has not been thoroughly characterised. Here, using whole-genome and RNA …
Y Funakoshi, N Hata, D Kuga, R Hatae, Y Sangatsuda… - Cancers, 2021 - mdpi.com
Simple Summary Recent research has enhanced our understanding of the diverse biological processes that occur in pediatric gliomas; and molecular genetic analysis has …
Abstract Background Nucleotide-specific 5-hydroxymethylcytosine (5hmC) remains understudied in pediatric central nervous system (CNS) tumors. 5hmC is abundant in the …
F Pacchiano, M Tortora, C Doneda, G Izzo… - World Journal of …, 2024 - Springer
Background The study of central nervous system (CNS) tumors is particularly relevant in the pediatric population because of their relatively high frequency in this demographic and the …
J Wyss, NA Frank, J Soleman, K Scheinemann - Cancers, 2022 - mdpi.com
Simple Summary Childhood glioblastoma is an aggressive brain tumor in children that has a very poor prognosis. Standard therapy includes surgery, irradiation and chemotherapy with …
T Gupta, C Sarkar, V Rajshekhar, S Chatterjee… - Neurology …, 2017 - journals.lww.com
Methods: The Indian Society of Neuro-Oncology (ISNO) constituted an expert multi- disciplinary panel with adequate representation from all stakeholders to prepare national …
F Malbari, H Lindsay - Pediatric Neurology, 2020 - Elsevier
Central nervous system tumors are the most common solid tumors in pediatrics and represent the largest cause of childhood cancer-related mortality. Improvements have …